Hendrianus The: Intravenous Cangrelor in Hemodynamically Unstable Patients Undergoing PCI
Hendrianus The, Interventional & Structural Cardiology Fellow at Heart and Brain Hospital, Chung-Ang University Medical Center, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I would like to share our recently published meta-analysis evaluating intravenous cangrelor in hemodynamically unstable patients undergoing PCI.
We found that IV cangrelor was associated with reduced mortality, with the most pronounced benefit observed in patients with cardiogenic shock, along with improved coronary flow.
These findings support its role as a valuable alternative when oral P2Y12 inhibitor administration is not feasible, pending confirmation in large-scale randomized trials.”
Title: Cangrelor in critically ill patients with cardiogenic shock or post-cardiac arrest undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Authors: Hendrianus Hendrianus, Young-Hoon Jeong, Sang Yeub Lee, Jun Hwan Cho, Jinhwan Jo, Diana A. Gorog, Jacek Kubica, Udaya S. Tantry, Paul A. Gurbel, Sang-Wook Kim
Read the Full Article on Critical Care
Stay updated with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia